Trial · NCT01197833
Adverse events48
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 48
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | extravasation | General disorders | Endovenous Ablation, Vehicle Placebo | 1 | 38 | 1 |
| other | extravasation | General disorders | Endovenous Ablation, Polidocanol Injectable Foam, 0.5% | 3 | 39 | 3 |
| other | extravasation | General disorders | Endovenous Ablation, Polidocanol Injectable Foam 1.0% | 2 | 40 | 2 |
| other | infusion site thrombosis | General disorders | Endovenous Ablation, Vehicle Placebo | 0 | 38 | 0 |
| other | infusion site thrombosis | General disorders | Endovenous Ablation, Polidocanol Injectable Foam, 0.5% | 3 | 39 | 3 |
| other | infusion site thrombosis | General disorders | Endovenous Ablation, Polidocanol Injectable Foam 1.0% | 3 | 40 | 3 |
| other | edema peripheral | General disorders | Endovenous Ablation, Vehicle Placebo | 0 | 38 | 0 |
| other | edema peripheral | General disorders | Endovenous Ablation, Polidocanol Injectable Foam, 0.5% | 1 | 39 | 1 |
| other | edema peripheral | General disorders | Endovenous Ablation, Polidocanol Injectable Foam 1.0% | 4 | 40 | 4 |
| other | tenderness | General disorders | Endovenous Ablation, Vehicle Placebo | 0 | 38 | 0 |
| other | tenderness | General disorders | Endovenous Ablation, Polidocanol Injectable Foam, 0.5% | 0 | 39 | 0 |
| other | tenderness | General disorders | Endovenous Ablation, Polidocanol Injectable Foam 1.0% | 3 | 40 | 3 |
| other | upper respiratory tract infection | Infections and infestations | Endovenous Ablation, Vehicle Placebo | 1 | 38 | 1 |
| other | upper respiratory tract infection | Infections and infestations | Endovenous Ablation, Polidocanol Injectable Foam, 0.5% | 2 | 39 | 2 |
| other | upper respiratory tract infection | Infections and infestations | Endovenous Ablation, Polidocanol Injectable Foam 1.0% | 0 | 40 | 0 |
| other | contusion | Injury, poisoning and procedural complications | Endovenous Ablation, Vehicle Placebo | 4 | 38 | 4 |
| other | contusion | Injury, poisoning and procedural complications | Endovenous Ablation, Polidocanol Injectable Foam, 0.5% | 7 | 39 | 7 |
| other | contusion | Injury, poisoning and procedural complications | Endovenous Ablation, Polidocanol Injectable Foam 1.0% | 5 | 40 | 5 |
| other | excoriation | Injury, poisoning and procedural complications | Endovenous Ablation, Vehicle Placebo | 0 | 38 | 0 |
| other | excoriation | Injury, poisoning and procedural complications | Endovenous Ablation, Polidocanol Injectable Foam, 0.5% | 2 | 39 | 2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01197833/events